Form 4: Aurinia Pharmaceuticals CEO Peter Greenleaf Reports Stock Sale to Cover Tax Obligations
SEC Form 4 Filing
Aurinia Pharmaceuticals' CEO, Peter Greenleaf, sold 126,981 shares of common stock on March 6, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 6, 2024, Peter Greenleaf, CEO of Aurinia Pharmaceuticals Inc., sold 126,981 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs) granted on March 2, 2022, and March 2, 2023.
- The shares were sold at a weighted average price of $5.6, with individual transactions ranging from $5.475 to $5.755.
- Following the transaction, Greenleaf directly owns 1,522,114 shares of Aurinia Pharmaceuticals Inc.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (stock sale for tax obligations) and doesn't inherently indicate positive or negative sentiment. It's a neutral event.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CEO's stock activity related to compensation and tax obligations, which is a common occurrence.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market, but it's unlikely to be significant given the relatively small volume compared to the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 2022/03/02 | Date of Restricted Stock Unit grant related to the stock sale. |
| 2023/03/02 | Date of Restricted Stock Unit grant related to the stock sale. |
| 2024/03/06 | Date of the stock sale transaction. |
| 2024/03/07 | Date of the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.